Dr. Benjamin Dekel is a Professor of Pediatrics, Human Genetics and Cellular Biochemistry and Klayman Chair of Nephro-Urology at Tel Aviv University. He is Chief of Pediatric Nephrology at the Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer and Director of the Pediatric Stem Cell Research Institute and Sagol Center for Regenerative Medicine, Sheba Medical Center, Tel Aviv University. He earned his MD at the Technion and PhD at the Weizmann Institute, did his Pediatrics and Pediatric Nephrology residency and fellowship at Sheba and Schneider Medical Center, and pursued post-doctoral research training at the Weizmann. He served as a visiting professor at Stanford’s Institute of Stem Cell Biology and Regenerative Medicine. Dr. Dekel’s research focuses on the interactions between progenitor cell types in the mammalian kidney that allow proper development and regeneration but can lead to congenital malformations, pediatric tumors and chronic kidney disease when malfunctioning. With over 130 peer-reviewed publications and supervision of clinical-scientists, clinicians and scientists that by now hold senior positions in medicine, academy and industry, his work has significantly advanced the understanding and treatment of kidney injuries and pediatric tumors. His multidisciplinary teams and a start up company he co-founded, RenoVate Bio, are pioneering new diagnostic and therapeutic methodologies for chronic kidney disease management.